Coronavirus vaccine could be approved in one year in EMA’s ‘optimistic’ scenario

Published: Updated:

A vaccine for the coronavirus could be ready in a year's time under an “optimistic” scenario, based on data from trials that are under way, the European Medicines Agency said Thursday.

Read the latest coronavirus updates in our dedicated section.

“We can see the possibility if everything goes as planned that some of them (vaccines) could be ready for approval in a year from now,” Marco Cavaleri, the EMA's head of biological health threats and vaccines strategy, told a video news conference.

“These are just forecasts based on what we are seeing. But again, I have to stress that this is a best-case scenario, we know not all vaccines that come into development may not make it to authorization and disappear,” he added.

“We know also that there may be delays.”

The agency was however “a bit skeptical” about reports that a vaccine could be ready as soon as September.

Read also: The UK says it will create COVID vaccine by autumn – but is it possible?

The Amsterdam-based EU agency meanwhile played down fears expressed by the World Health Organization that the virus “may never go away.”

“I think it's a bit early to say but we have good reason to be sufficiently optimistic that some vaccines will make it,” Cavaleri said.

“I would be surprised that if at the end of the day we don't have any vaccine for COVID-19.”

Read more:

For all the latest headlines follow our Google News channel online or via the app.

Two strains, 70 mutations of COVID-19 exist in the UAE, study finds

Mental health, work-life balance crucial for life after coronavirus, say experts